Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.
Introduced
Jan 8, 2025
Last Action
Feb 3, 2025
Session
NY 2025-2026
Sponsors
1 primary · 5 co
DELIVERED TO GOVERNOR
APPROVAL MEMO.1
SIGNED CHAP.7
RETURNED TO SENATE
PASSED ASSEMBLY
SUBSTITUTED FOR A2145A
ORDERED TO THIRD READING RULES CAL.61
REFERRED TO HIGHER EDUCATION
COMMITTEE DISCHARGED AND COMMITTED TO RULES
ORDERED TO THIRD READING CAL.99
PASSED SENATE
DELIVERED TO ASSEMBLY
PRINT NUMBER 36A
AMEND (T) AND RECOMMIT TO HIGHER EDUCATION
REFERRED TO HIGHER EDUCATION
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
APPROVAL MEMO.1